IL-21 promotes CD4 t cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2195-2201

  Attridge, Kesley ^a,d   Kenefeck, Rupert ^b   Wardzinski, Lukasz ^a,b   Qureshi, Omar S ^a   Wang, Chun Jing ^b   Manzotti, Claire ^a   Okkenhaug, Klaus ^c   Walker, Lucy S K ^a,b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; INTERLEUKIN 21; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIGENS, CD86; B-LYMPHOCYTES; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84897902772     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302082     Document Type: Article

References (65)

1. Ma, H. L., M. J. Whitters, R. F. Konz, M. Senices, D. A. Young, M. J. Grusby, M. Collins, and K. Dunussi-Joannopoulos. 2003. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-g. J. Immunol. 171: 608-615.
2. Ugai, S., O. Shimozato, K. Kawamura, Y. Q. Wang, T. Yamaguchi, H. Saisho, S. Sakiyama, and M. Tagawa. 2003. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther. 10: 187-192.
3. Hinrichs, C. S., R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo. 2008. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111: 5326-5333.
4. Fewkes, N. M., and C. L. Mackall. 2010. Novel g-chain cytokines as candidate immune modulators in immune therapies for cancer. Cancer J. 16: 392-398.
5. Markley, J. C., and M. Sadelain. 2010. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood 115: 3508-3519.
6. De Totero, D., R. Meazza, M. Capaia, M. Fabbi, B. Azzarone, E. Balleari, M. Gobbi, G. Cutrona, M. Ferrarini, and S. Ferrini. 2008. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 111: 517-524.
7. Gowda, A., J. Roda, S. R. Hussain, A. Ramanunni, T. Joshi, S. Schmidt, X. Zhang, A. Lehman, D. Jarjoura, W. E. Carson, et al. 2008. IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood 111: 4723-4730.
8. Sarosiek, K. A., R. Malumbres, H. Nechushtan, A. J. Gentles, E. Avisar, and I. S. Lossos. 2010. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood 115: 570-580.
9. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, III, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
10. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371.
11. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
12. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
13. Linterman, M. A., L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava, J. J. Hogan, N. K. Verma, M. J. Smyth, R. J. Rigby, and C. G. Vinuesa. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
14. Gagnon, J., X. L. Chen, M. Forand-Boulerice, C. Leblanc, C. Raman, S. Ramanathan, and S. Ilangumaran. 2010. Increased antigen responsiveness of naive CD8 T cells exposed to IL-7 and IL-21 is associated with decreased CD5 expression. Immunol. Cell Biol. 88: 451-460.
15. Ramanathan, S., S. Dubois, X. L. Chen, C. Leblanc, P. S. Ohashi, and S. Ilangumaran. 2011. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes. J. Immunol. 186: 5131-5141.
16. Peluso, I., M. C. Fantini, D. Fina, R. Caruso, M. Boirivant, T. T. MacDonald, F. Pallone, and G. Monteleone. 2007. IL-21 counteracts the regulatory T cellmediated suppression of human CD4+ T lymphocytes. J. Immunol. 178: 732-739.
17. Clough, L. E., C. J. Wang, E. M. Schmidt, G. Booth, T. Z. Hou, G. A. Ryan, and L. S. Walker. 2008. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J. Immunol. 180: 5393-5401.
18. Woyach, J. A., A. J. Johnson, and J. C. Byrd. 2012. The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood 120: 1175-1184.
19. Attridge, K., C. J. Wang, L. Wardzinski, R. Kenefeck, J. L. Chamberlain, C. Manzotti, M. Kopf, and L. S. Walker. 2012. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 119: 4656-4664.
20. Fröhlich, A., B. J. Marsland, I. Sonderegger, M. Kurrer, M. R. Hodge, N. L. Harris, and M. Kopf. 2007. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109: 2023-2031.
21. Curiel, R. E., C. S. Garcia, S. Rottschafer, M. C. Bosco, and I. Espinoza-Delgado. 1999. Enhanced B7-2 gene expression by interferon-g in human monocytic cells is controlled through transcriptional and posttranscriptional mechanisms. Blood 94: 1782-1789.
22. Zeng, R., R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard. 2007. The molecular basis of IL-21-mediated proliferation. Blood 109: 4135-4142.
23. Brenne, A. T., T. B. Ro, A. Waage, A. Sundan, M. Borset, and H. Hjorth-Hansen. 2002. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 99: 3756-3762.
24. Good, K. L., V. L. Bryant, and S. G. Tangye. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177: 5236-5247.
25. Avery, D. T., C. S. Ma, V. L. Bryant, B. Santner-Nanan, R. Nanan, M. Wong, D. A. Fulcher, M. C. Cook, and S. G. Tangye. 2008. STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 112: 1784-1793.
26. Ostiguy, V., E. L. Allard, M. Marquis, J. Leignadier, and N. Labrecque. 2007. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J. Leukoc. Biol. 82: 645-656.
27. Marshall-Clarke, S., L. Tasker, M. P. Heaton, and R. M. Parkhouse. 2003. A differential requirement for phosphoinositide 3-kinase reveals two pathways for inducible upregulation of major histocompatibility complex class II molecules and CD86 expression by murine B lymphocytes. Immunology 109: 102-108.
28. Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S. E. Meek, A. Salpekar, M. D.Waterfield, et al. 2002. Impaired B and T cell antigen receptor signaling in p110d PI 3-kinase mutant mice. Science 297: 1031-1034.
29. Bilancio, A., K. Okkenhaug, M. Camps, J. L. Emery, T. Ruckle, C. Rommel, and B. Vanhaesebroeck. 2006. Key role of the p110d isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110d function in B cells. Blood 107: 642-650.
30. Beer-Hammer, S., E. Zebedin, M. von Holleben, J. Alferink, B. Reis, P. Dresing, D. Degrandi, S. Scheu, E. Hirsch, V. Sexl, et al. 2010. The catalytic PI3K isoforms p110g and p110d contribute to B cell development and maintenance, transformation, and proliferation. J. Leukoc. Biol. 87: 1083-1095.
31. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
32. Mehta, D. S., A. L. Wurster, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170: 4111-4118.
33. Jin, H., R. Carrio, A. Yu, and T. R. Malek. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bimdependent apoptosis. J. Immunol. 173: 657-665.
34. Kwon, H., D. Thierry-Mieg, J. Thierry-Mieg, H. P. Kim, J. Oh, C. Tunyaplin, S. Carotta, C. E. Donovan, M. L. Goldman, P. Tailor, et al. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31: 941-952.
35. Brandt, K., S. Bulfone-Paus, D. C. Foster, and R. Rückert. 2003. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102: 4090-4098.
36. Strengell, M., A. Lehtonen, S. Matikainen, and I. Julkunen. 2006. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J. Leukoc. Biol. 79: 1279-1285.
37. Maeda, M., Y. Yanagawa, K. Iwabuchi, K. Minami, Y. Nakamaru, D. Takagi, S. Fukuda, and K. Onoé. 2007. IL-21 enhances dendritic cell ability to induce interferon-g production by natural killer T cells. Immunobiology 212: 537-547.
38. Van Belle, T. L., S. Nierkens, R. Arens, and M. G. von Herrath. 2012. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 36: 1060-1072.
39. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
40. Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
41. Qureshi, O. S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
42. Walker, L. S., and D. M. Sansom. 2011. The emerging role of CTLA4 as a cellextrinsic regulator of T cell responses. Nat. Rev. Immunol. 11: 852-863.
43. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
44. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988.
45. Moudgil, K. D., and D. Choubey. 2011. Cytokines in autoimmunity: role in induction, regulation, and treatment. J. Interferon Cytokine Res. 31: 695-703.
46. Herber, D., T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830.
47. Dolff, S.,W. H. Abdulahad, J.Westra, B. Doornbos-van der Meer, P. C. Limburg, C. G. Kallenberg, and M. Bijl. 2011. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 13: R157.
48. O'Neill, S. K., Y. Cao, K. M. Hamel, P. D. Doodes, G. Hutas, and A. Finnegan. 2007. Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. J. Immunol. 179: 5109-5116.
49. Chtanova, T., S. G. Tangye, R. Newton, N. Frank, M. R. Hodge, M. S. Rolph, and C. R. Mackay. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173: 68-78.
50. Rasheed, A. U., H. P. Rahn, F. Sallusto, M. Lipp, and G. Müller. 2006. Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36: 1892-1903.
51. Lüthje, K., A. Kallies, Y. Shimohakamada, G. T. Belz, A. Light, D. M. Tarlinton, and S. L. Nutt. 2012. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat. Immunol. 13: 491-498.
52. Salek-Ardakani, S., Y. S. Choi, M. Rafii-El-Idrissi Benhnia, R. Flynn, R. Arens, S. Shoenberger, S. Crotty, M. Croft, and S. Salek-Ardakani. 2011. B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus. J. Immunol. 186: 5294-5303.
53. Deszo, E. L., D. K. Brake, K.W. Kelley, and G. G. Freund. 2004. IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta. Cell. Signal. 16: 271-280.
54. Polak, R., and M. Buitenhuis. 2012. The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia. Blood 119: 911-923.
55. Hoellenriegel, J., S. A. Meadows, M. Sivina, W. G. Wierda, H. Kantarjian, M. J. Keating, N. Giese, S. O'Brien, A. Yu, L. L. Miller, et al. 2011. The phosphoinositide 39-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood 118: 3603-3612.
56. Jin, H., and T. R. Malek. 2006. Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21. J. Leukoc. Biol. 80: 1416-1423.
57. Avery, D. T., V. L. Bryant, C. S. Ma, R. De Waal Malefyt, and S. G. Tangye. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181: 1767-1779.
58. Rolf, J., S. E. Bell, D. Kovesdi, M. L. Janas, D. R. Soond, L. M. Webb, S. Santinelli, T. Saunders, B. Hebeis, N. Killeen, et al. 2010. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185: 4042-4052.
59. Yusuf, I., R. Kageyama, L. Monticelli, R. J. Johnston, D. Ditoro, K. Hansen, B. Barnett, and S. Crotty. 2010. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J. Immunol. 185: 190-202.
60. King, I. L., and M. Mohrs. 2009. IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 206: 1001-1007.
61. Mitsdoerffer, M., Y. Lee, A. Jäger, H. J. Kim, T. Korn, J. K. Kolls, H. Cantor, E. Bettelli, and V. K. Kuchroo. 2010. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. USA 107: 14292-14297.
62. Patakas, A., R. A. Benson, D. R. Withers, P. Conigliaro, I. B. McInnes, J. M. Brewer, and P. Garside. 2012. Th17 effector cells support B cell responses outside of germinal centres. PLoS ONE 7: e49715.
63. Yoon, S. O., X. Zhang, P. Berner, and Y. S. Choi. 2009. IL-21 and IL-10 have redundant roles but differential capacities at different stages of plasma cell generation from human germinal center B cells. J. Leukoc. Biol. 86: 1311-1318.
64. Niu, H., G. Cattoretti, and R. Dalla-Favera. 2003. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J. Exp. Med. 198: 211-221.
65. Good-Jacobson, K. L., E. Song, S. Anderson, A. H. Sharpe, and M. J. Shlomchik. 2012. CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. J. Immunol. 188: 4217-4225.